FICKENSCHER JAMES E (Chief Financial Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/9/2023ACC: 0000899243-23-004444
Officer· Chief Financial Officer
Since Aug 2018
+16K
Net shares
Net buyer
$3.9K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
22.55K acquired · 6.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.55K
Price / share
—
Trade value
—
% of position
6.6%
2/7/2023
339.88K→362.43K
Common Stock
Direct
Shares
−6.54K
Price / share
$0.60
Trade value
$3.90K
% of position
1.8%
2/8/2023
362.43K→355.88K
Total
Net shares
+16K
Net value
-$3.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2023 | A · Award | +22.55K | — | — | 6.6% | 339.88K | 362.43K |
| Common Stock Direct | 2/8/2023 | F · Tax Withholding | −6.54K | $0.60 | $3.90K | 1.8% | 362.43K | 355.88K |
| Total | +16K | -$3.90K | ||||||
Derivative Transactions0
No derivative transactions reported